METZGER MICHAEL A (President and COO) sold 2.5% of their position (7.81K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $117.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2025ACC: 0000950170-25-034634
Officer· President and COO
Since Feb 2019
+7.81K
Net shares
Net buyer
$117.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.63K acquired · 7.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.81K
Price / share
$7.20
Trade value
$56.26K
% of position
2.6%
3/4/2025
300.12K→307.94K
Common Stock
Direct
Shares
−7.81K
Price / share
$15.05
Trade value
$117.56K
% of position
2.5%
3/4/2025
307.94K→300.12K
Total
Net shares
+0.00
Net value
-$61.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2025 | M · Option Exercise | +7.81K | $7.20 | $56.26K | 2.6% | 300.12K | 307.94K |
| Common Stock Direct | 3/4/2025 | S · Sale | −7.81K | $15.05 | $117.56K | 2.5% | 307.94K | 300.12K |
| Total | +0.00 | -$61.30K | ||||||
Derivative Transactions1
Stock options (Right to buy)
Direct
Converts to
Common Stock
7.81K shares
Shares
+7.81K
Strike price
7.2
Held after
0.00
Exercisable
—
3/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (Right to buy) Direct | Common Stock7.81K shares | 3/4/2025 | M · Option Exercise | +7.81K | 7.2 | — | 0.00 |